METTL3 may maintain the characteristics of bladder cancer stem cells by inducing the m6A modification of SOX2(SRY-Box Transcription Factor 2), a marker of bladder cancer stem cells both in vivo and in vitro (Zhu et al., 2017). The gene discussed is METTL3; the disease is urinary bladder carcinoma.